Anti-cyclic citrullinated peptide (CCP) antibody in patients with wood-smoke-induced chronic obstructive pulmonary disease (COPD) without rheumatoid arthritis

Rheumatology International

Volumn 35, Issue 1, 2015, Pages 85-91

  Sigari, Naseh ^a   Moghimi, Nasrin ^a   Shahraki, Farhad Saber ^a   Mohammadi, Shilan ^a   Roshani, Daem ^a  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti CCP; COPD; Rheumatoid arthritis; Wood smoke

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; TOBACCO SMOKE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; WOOD SMOKE; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; SMOKE;

ADULT; AIRFLOW; ANTIBODY TITER; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; TOBACCO; ADVERSE EFFECTS; AGED; BLOOD; IMMUNOLOGY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHEUMATOID ARTHRITIS; SMOKE;

AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE;

EID: 84926652561     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3083-2     Document Type: Article

References (29)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(4):347-365
2. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L et al (2004) The nature of small-airway obstruction in chronic pulmonary disease. N Engl J Med 350:2645-2653
3. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, Pilewski JM, Stoner MW, Csizmadia E et al (2008) Autoantibodies in patients with chronic obstructive disease. Am J Respir Crit Care Med 177:156-163
4. Cainelli F, Betterle C, Vento S (2004) Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus. Ann Rheum Dis 63:1707-1708
5. Nunez B, Sauleda J, Anto JM, Julia MR, Orozco M, Monso E et al (2011) Anti-tissue antibodies are related to lung function in chronic obstructive lung disease. Am J Respir Crit Care Med 183:1025-1031
6. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR et al (2005) An animal model of autoimmune emphysema. Am J Respir Crit Care Med 171:734-742
7. Amson Y, Shoenfeld Y, Amital H (2010) Effect of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 35:258-265
8. Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L et al (2006) Citrullination is an inflammationdependent process. Ann Rheum Dis 65:1219-1222
9. Makrygiannakis D, Hermansson M, Ulfgren A-K, Nicolas AP, Zendman AJ, Eklund A et al (2008) Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increase citrullination in BAL cells. Ann Rheum Dis 67:1488-1492
10. Wood AM, de Pablo P, Bukley CD, Ahmed A, Stockley RA (2011) Smoke exposure as a determinant of autoantibody titre in α1-antitrypsin deficiency and COPD. Eur Respir J 37:32-38
11. Van Gaalen FA, Lin-Rasker SP, van Venrooij WJ, de Long BA, Breedveld FC, BAVerweij CL et al (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3):709-715
12. Van Venrooj WJ, Hazes JMW, Visser H (2002) Anti-citrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60:383-388
13. Soderlin M, Petersson I, Bergman S, Svensson B (2011) Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA. Scand J Rheumatol 40(4):249-255
14. Ruiz-Esquide V, Gomera MJ, Peinado VI, Puerta JAG, Barbera JA, de Dios Canete J et al (2012) Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol 31(7):1047-1050
15. Salvi SS, Barnes PJ (2009) Chronic obstructive pulmonary disease in non-smokers. Lancet 374:733-743
16. Cell BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932-946
17. Jones PW, Harding P, Berry P, Wiklund I, Chen WH, Leidy NK (2009) Development and first validation of the COPD assessment test. Eur Respir J 34:648-654
18. Miravitalles M, Garcia-Sidro P, Fernandez-Nistal A, Buendia MJ, de los Monteros MJE, Molina J (2013) Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcome 11:147
19. Mahler DA, Wells CK (1998) Evaluation of clinical methods for rating dyspnea. Chest 93:580-586
20. Vossenaar ER, Zendman AJ, van Venrooji WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioassay 25:1106-1118
21. Klareskog L, Stolt P, Lundberg K, lberg HK, Bengtsson C, Grunewald J et al (2006) Smoking may trigger HLA-DR (Shared Epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rh 54:38-46
22. Mandl LA, Chibnik L, Schur P, Karlson EW (2005) Anti-cyclic citrullinated peptide (Anti-CCP) antibodies are strongly associated with risk of rheumatoid arthritis after adjusting for hormonal and behavioral factors. Arthritis Rheum 52(suppl.):S732
23. Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L (2009) Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti citrullinated protein antibody positive rheumatoid arthritis. Arthritis Rheum 60:1597-1603
24. Elkayan O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65:1110-1112
25. Fischer A, Solomon JJ, du Bois RM, Deane KD, Olson AL, Fernandez-Perez ER et al (2012) Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106(7):1040-1047
26. Rivera RM, Cosio MG, Ghezzo H, Salazar M, Perez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 12:927-977
27. Ruiz-Esquide V, Sanmart R (2012) Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatol Clin 8(6):342-350
28. Bergstro U, Jacobsson LTH, Nilsson JA, Berglund G, Turesson C (2011) Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology 50:2005-2013
29. Roy K, Smith J, Kolsum U, Borrill Z, Vestbo J, Singh D (2009) COPD phenotype description using principal components analysis. Respir Res 10:41